Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Nannan Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4334-2767; OpenAlex author ID A5109484480. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 2 papers

Papers 3

  1. HNRNPC regulates RhoA to induce DNA damage repair and cancer-associated fibroblast activation causing radiation resistance in pancreatic cancer. First author DOI 10.1111/jcmm.17254↗
  2. hnRNPC Promotes Malignancy in Pancreatic Cancer through Stabilization of IQGAP3. Co-author DOI 10.1155/2022/6319685↗
  3. Robo1-specific chimeric antigen receptor natural killer cell therapy for pancreatic ductal adenocarcinoma with liver metastasis. First author DOI 10.4103/jcrt.jcrt_190_20↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhongmin Wang · 2 shared papers, 2020–2022 · strength 0.35
  2. Xiaoyu Liu · 2 shared papers, 2022 · strength 0.34
  3. Chaojie Li · 1 shared paper, 2020 · strength 0.16
  4. Ning Xia · 1 shared paper, 2022 · strength 0.16
  5. Wei Huang · 1 shared paper, 2022 · strength 0.16
  6. Zhongmin Wang · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.